This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 3.43% to $1.97 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.89% to 26,853.98 and Dow Jones Industrial Average falling 1.21% to 50,687.07.
This was the stock's third consecutive day of losses.
TherapeuticsMD Inc. closed 33.22% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) rose 0.80% to $217.13.
Trading volume (44,059) eclipsed its 50-day average volume of 23,917.
Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-03-26 1731ET

TXMD

TherapeuticsMD Inc. (TXMD) shares fell 3.43% to $1.97 on Wednesday, underperforming competitors like AbbVie amid a broader market decline. This marks the stock's third consecutive day of losses, with prices now 33.22% below its 52-week high. Trading volume significantly exceeded the 50-day average.

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors